Zyus Life Sciences Inc. — Form D/A
Zyus Life Sciences Inc. of SASKATOON, A9, a company, filed a Form D amendment with the SEC on 2021-01-06. The offering totals $19.2M, of which $15.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-01-06
- Form: D/A
- Accession: 0001757610-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $19.2M
- Amount sold: $15.1M
- Remaining: $4.1M
- Investors: 6
- Date of first sale: 2020-11-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-383001
Issuer
- Name: Zyus Life Sciences Inc.
- CIK: 0001757610
- Entity type: Corporation
- Jurisdiction: SASKATCHEWAN, CANADA
- Incorporated: 2018
- Address: 407 DOWNEY RD, SASKATOON, A9, S7N 4L8
- Phone: 306-651-7711
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Michelle Gursky | Executive Officer | Saskatoon, A9 |
| Larry Holbrook | Executive Officer | Saskatoon, A9 |
| John Knowles | Director | Saskatoon, A9 |
| Keith Carpenter | Executive Officer | Saskatoon, A9 |
| Garnette Weber | Director | Saskatoon, A9 |
| Richard Hoyt | Director | Saskatoon, A9 |
| John Hyshka | Executive Officer | Saskatoon, A9 |
| Brent Zettl | Director | Saskatoon, A9 |
| Brent Zettl | Executive Officer | Saskatoon, A9 |
| Dr. Lionel Marks de Chabris | Executive Officer | SASKATOON, A9 |
| Rob Harding | Executive Officer | SASKATOON, A9 |
| Donald Ching | Director | SASKATOON, A9 |
| Adam Darbellay | Executive Officer | SASKATOON, A9 |
| Allan Fowler | Executive Officer | SASKATOON, A9 |
Other filings by this issuer (7)
More